Astrix Technology LLC

Astrix Technology LLC, doing business as Astrix Technology Group, is a Red Bank, New Jersey-based for-profit limited liability company that supplies scientific, research, technical, and administrative personnel to the federal biomedical research enterprise as a prime contractor, competing on an unrestricted, full-and-open basis across the GSA Multiple Award Schedule (MAS) vehicle. The company does not hold SBA set-aside certifications and operates as a mainstream commercial contractor, with no apparent sub-award footprint—the vendor acts exclusively as a prime, delivering over 1,300 awards to federal agencies, predominantly the National Institutes of Health and its constituent institutes.

Astrix's core capability is flexible, task-order-based staffing of specialized scientific, clinical, and administrative personnel to support ongoing biomedical research operations. Representative work includes scientific researchers, clinical research nurses, laboratory technicians, biostatisticians, program managers, regulatory specialists, and data analysts deployed across NIH institutes to backfill ongoing research initiatives, support clinical trials, manage grant administration, and handle laboratory operations. The company places personnel at all performance levels, from junior scientific researchers (GSA labor rate $97.93/hr) through senior subject matter experts ($282.25/hr), with education requirements typically bachelor's degrees or higher. SCI-reported invoiced revenue totaled $29.5 million across FY2022–FY2024, with median government-paid hourly rates around $72.92/hr and senior rates through $139.81/hr. Notable recent awards include a $1.75 million LabVantage LIMS Phase V implementation for the U.S. Department of Agriculture, $756,580 for National Eye Institute scientific and clinical support, and $630,716 for National Institute of Allergy and Infectious Diseases clinician staffing.

Customer concentration is heavily weighted to NIH. The top five customer agencies account for 81% of recent award count, led by the National Heart, Lung and Blood Institute (399 awards, $62.3 million potential value), National Cancer Institute (382 awards, $155.8 million), and the NIH Office of Logistics and Acquisition Operations (184 awards, $77.4 million). When ranked by potential dollars, the National Cancer Institute rises to first place ($155.8 million), followed by the Office of Logistics and Acquisition Operations ($77.4 million) and NHLBI ($62.3 million). Astrix holds two single-award BPAs with NIH: a $20 million vehicle through May 31, 2025 for scientific support, office support, and temporary help services across multiple institutes; and a $19.41 million NIDCD-specific vehicle running through September 25, 2027 for similar services. Task orders under these BPAs flow consistently, with values typically $10,000 to $600,000 per order.

Activity has contracted materially over the past five years—from 191 awards in 2022 to 25 in 2026 (annualized through mid-July). FY2023 and FY2024 show steeper declines: 135 awards and 100 awards respectively. SCI-reported FTE headcount tracking federal service contracts also fell, from 81 FTEs in FY2022 to 40.9 FTEs in FY2024. Within the next twenty-four months, 70 awards carrying $29.9 million in combined potential value reach ultimate completion, representing meaningful recompete exposure as Astrix's core NIH BPA vehicles approach renewal or expiration.

The vendor's sole parent vehicle is the GSA MAS, under which all 1,354 task orders sit. Astrix does not hold agency-specific GWACs, IDIQs, or other parent vehicles beyond the two NIH BPAs noted. The labor portfolio spans 16 active GSA categories priced from $55.30/hr (junior biologist) to $282.25/hr (senior subject matter expert), with no security clearances offered. Across SCI-reportable prime contracts, subs performed 0% of hours, confirming Astrix builds its own delivery teams without material subcontractor dependency—a hallmark of the staffing model. The vendor's limited non-NIH footprint includes sporadic work for USDA (Kansas City grain-inspection lab support), the NIH-affiliated Science and Technology Program (Gastonia, North Carolina research support), and National Institute of Arthritis and Musculoskeletal and Skin Diseases. The single identified subcontract is a recent Leidos engagement supporting research information technology capabilities (awarded September 2025, running through February 2028), representing minimal sub-prime presence.